Repligen (RGEN) Corporation announced the grand opening of its new Repligen Training & Innovation Center at its OPUS Pre-packed Chromatography Columns manufacturing facility in Breda, the Netherlands. The RTIC buildout, which features product exhibits and purpose-built demonstration areas, was designed to provide customers with pre- and post-sales support, and a hands-on experience with Repligen’s innovative bioprocessing solutions.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RGEN:
- Repligen initiated with a Buy at Rothschild & Co Redburn
- Repligen price target lowered to $145 from $175 at Barclays
- Repligen price target lowered to $140 from $170 at Evercore ISI
- Repligen: Strong Execution, Innovation, and Cross‑Selling Momentum Support Sustained Growth and Reaffirmed Buy Rating
- Repligen price target raised to $208 from $180 at H.C. Wainwright